triiodothyronine has been researched along with gadolinium dtpa in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gahide, G; Hoa, D; Vendrell, JF | 1 |
| Gerdes, AM; Iervasi, G; Katz, SD; Tang, YD; Wang, W; Zhang, K; Zhao, S | 1 |
2 other study(ies) available for triiodothyronine and gadolinium dtpa
| Article | Year |
|---|---|
Mature teratoma arising from the sella.
Topics: Contrast Media; Gadolinium DTPA; Humans; Hyperphagia; Infant; Magnetic Resonance Imaging; Male; Pituitary Neoplasms; Prolactin; Sella Turcica; Teratoma; Thyrotropin; Tomography, X-Ray Computed; Triiodothyronine; Vision Disorders; Visual Acuity | 2010 |
Long-term prognostic value of combined free triiodothyronine and late gadolinium enhancement in nonischemic dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Cause of Death; China; Contrast Media; Female; Follow-Up Studies; Gadolinium DTPA; Heart Ventricles; Humans; Image Enhancement; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Survival Rate; Time Factors; Triiodothyronine | 2018 |